Acadia Healthcare (NASDAQ:ACHC) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Acadia Healthcare (NASDAQ:ACHC) issued its quarterly earnings data on Wednesday. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01, Briefing.com reports. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 earnings per share. Acadia Healthcare updated its FY24 guidance to $3.35-$3.45 EPS and its FY 2024 guidance to 3.350-3.450 EPS.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $42.69 on Friday. Acadia Healthcare has a 12 month low of $42.46 and a 12 month high of $87.77. The stock has a fifty day moving average price of $67.15 and a 200-day moving average price of $68.18. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. The firm has a market cap of $3.96 billion, a PE ratio of 14.00, a P/E/G ratio of 1.57 and a beta of 1.29.

Analysts Set New Price Targets

Several research firms have commented on ACHC. KeyCorp assumed coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Barclays cut their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $86.67.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.